Yiqun Bai - Profile and Investment Details

Investor Profile

Yiqun Bai is a Venture Capital, Entrepreneurship Program, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods, Inzen Therapeutics, Ohana Biosciences, T2 Biosystems, Tangent Medical Technologies, Kaleido BioSciences, Permeon Biologics, Kovio, Oasys Water, Editas Medicine, Tessera Therapeutics, Ring Therapeutics, Moderna Therapeutics, Omega Therapeutics, Cygnal Therapeutics, Sana Biotechnology, Seres Therapeutics, Agios Pharmaceuticals, Red Rock Biofuels, Tarveda Therapeutics, Receptos, Repertoire Immune Medicines, Generate Biomedicines, Codiak Biosciences, BlackDuck, Polatis, Seventh Sense Biosystems, Sigilon Therapeutics, Boragen, TARIS Biomedical, TransMedics, Selecta Biosciences, Quanterix, Visterra, Sesen Bio, Inc., CiBO Technologies, medidametrics, Rubius Therapeutics, Axcella, Senda Biosciences, Foghorn Therapeutics, Evelo Biosciences, Inari, Joule Unlimited Technologies, Cellarity, WikiCell Designs, Avedro, Indigo, EcoSense Lighting, Valo Health, Invaio Sciences, . Over time, Yiqun Bai has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Yiqun Bai is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Creative Venture, Clean Tech, Health Care, Research and Development, Regenerative Medicine, Drug Discovery, Wellness, Women Founded, Enterprise Software, Energy, Healthcare Innovation, Strategic Partnerships, Chemical, Life Science, Engineering, Artificial Intelligence (AI), Science, Venture Fundraising, Synthetic Biology, Biotechnology, Medical Devices, Drug Development, Hispanic / Latinx Founded, Clean Technology, Market Research, Entrepreneurship, Innovation, Clinical Trials, Groceries, Disruptive technology, Research, Agriculture, Personalized Medicine, Health Diagnostics, Social Impact, Innovation Management, Oil and Gas, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Health Tech, Media and Entertainment, Machine Learning, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Yiqun Bai, as their portfolio suggests a familiarity and interest in this area.

Understanding Yiqun Bai’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.